# TReating Incontinence for Underlying Mental and Physical Health

> **NCT05362292** · PHASE4 · RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 270 (estimated)

## Conditions studied

- Urinary Incontinence, Urge
- Urinary Incontinence
- Overactive Bladder
- Incontinence, Urge
- Incontinence, Urinary
- Incontinence

## Interventions

- **DRUG:** Tolterodine Tartrate ER
- **DRUG:** Mirabegron
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05362292
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-04
- **Primary completion:** 2027-05-02
- **Final completion:** 2027-08-02
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2026-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05362292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05362292, "TReating Incontinence for Underlying Mental and Physical Health". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05362292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*